Empagliflozin, sold under the brand name Jardiance, among others, is an antidiabetic medication used to improve glucose control in people with type 2... 30 KB (2,501 words) - 06:21, 7 April 2024 |
Empagliflozin/metformin, sold under the brand name Synjardy among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes... 9 KB (558 words) - 19:21, 17 March 2024 |
Empagliflozin/linagliptin, sold under the brand name Glyxambi, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. It... 9 KB (546 words) - 00:40, 15 March 2024 |
Empagliflozin/linagliptin/metformin, sold under the brand name Trijardy XR, is a drug combination used for the treatment of type 2 diabetes. It is a combination... 8 KB (345 words) - 19:31, 20 December 2023 |
Empagliflozin, approved in the United States in August 2014, under the brand name Jardiance by Boehringer Ingelheim. Of the gliflozins, empagliflozin... 44 KB (4,550 words) - 18:20, 14 April 2024 |
studies have shown that dapagliflozin is superior to others such as empagliflozin. In the European Union, dapagliflozin is indicated in adults: For the... 52 KB (4,829 words) - 04:26, 20 April 2024 |
Metformin and gemigliptin A10BD19 Linagliptin and empagliflozin A10BD20 Metformin and empagliflozin A10BD21 Saxagliptin and dapagliflozin A10BD22 Metformin... 6 KB (508 words) - 06:49, 20 December 2023 |
Another triple combination approval for metformin, linagliptin, and empagliflozin followed in 2020. Diabetes medications have four main mechanisms of... 49 KB (5,098 words) - 10:55, 4 April 2024 |
dapagliflozin (Farxiga in US, Forxiga in EU), canagliflozin (Invokana) and empagliflozin (Jardiance). Certain SGLT2 inhibitors have shown to reduce mortality... 10 KB (965 words) - 19:41, 31 December 2023 |
side effect of SGLT2 inhibitors (canagliflozin, dapagliflozin, and empagliflozin), which increase the excretion of glucose in the urine. Fournier gangrene... 11 KB (921 words) - 23:49, 15 April 2024 |
Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin... 35 KB (3,927 words) - 15:37, 18 March 2024 |
Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin... 4 KB (262 words) - 03:35, 22 March 2024 |
combinations of metformin with the SGLT-2 inhibitors dapagliflozin, empagliflozin, and canagliflozin. Sulfonylureas act by increasing insulin release... 142 KB (13,772 words) - 06:08, 27 April 2024 |
Administration (FDA) in the United States; dapagliflozin, canagliflozin and empagliflozin. Canagliflozin was the first SGLT-2 inhibitor that was approved by the... 26 KB (3,184 words) - 22:21, 29 August 2023 |
Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin... 7 KB (446 words) - 21:52, 2 April 2024 |
(soluble) Intermediate-acting insulin Long-acting insulin analogues Empagliflozin Gliclazide Metformin Complementary: Metforminα Glucagon Complementary:... 77 KB (4,835 words) - 05:22, 23 March 2024 |
temporarily before scheduled surgery. Canagliflozin, dapagliflozin, and empagliflozin should each be stopped at least three days before, and ertugliflozin... 8 KB (370 words) - 07:16, 24 March 2024 |